Method of detecting gene mutation
CA 2506654 C · Owner: Sekisui Medical Co. Ltd. · Inventors: Matsubara, Yoichi; Kure, Shigeo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
DNA amplification and hybridization are successively carried out in a reaction system containing primers for the DNA amplification and hybridization probes followed by , detecting the hybrid in the reaction solution by affinity chromatography wherein at least one , of the primers to be used in the DNA amplification is labeled with a first labeling agent so , that the amplified DNA will be labeled with the first labeling agent a , hybridization probe is , labeled with a second labeling agent and contained in a reaction solution for effecting the , DNA amplification, the base sequence of the hybridization probe is designed not to inhibit , the DNA amplification and a hybrid is detected by …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 7, 2003 and granted February 25, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 7, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 7, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.